Context Solid organ transplant recipients have elevated cancer risk due to
immunosuppression and oncogenic viral infections. Because most prior research has …

Background Transplant recipients have an elevated risk of cancer because of
immunosuppressive medications used to prevent organ rejection, but to the authors' …

Iatrogenic immunosuppression is a unique setting for investigating immune‐related
mechanisms of carcinogenesis. Solid organ transplant recipients have a 3‐fold excess risk …

Background. Transplant recipients are at increased risk of malignancy; however, the
influence of transplantation on cancer outcomes has not been rigorously defined. The …

BACKGROUND Solid organ transplantation recipients have elevated cancer incidence.
Estimates of absolute cancer risk after transplantation can inform prevention and screening …

Importance Solid-organ transplant recipients (SOTRs) are at greater risk of developing some
cancers than the general population; however, because they are also at increased risk of …

Over the past decades, there has been an encouraging increase in survival after solid organ
transplantation. However, with longer life spans, more transplant recipients are at risk of …

Background. Organ donation may involve the risk of transmittal of unwanted host factors
such as infections and malignancy. These may be concealed in the emergent donation …

Background It is unclear to what extent cancer history affects posttransplantation mortality in
solid organ transplant recipients. Methods We identified a Swedish population-based cohort …

Population-based evidence on the relative risk of de novo cancer in liver and cardiothoracic
transplant recipients is limited. A cohort study was conducted in Australia using population …